Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-27 Sale | 2024-02-27 7:54 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,405 | $0.7322 | $2,493 | 136,750 (Direct) | View |
| 2023-11-28 Sale | 2023-11-28 7:06 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,720 | $0.5 | $1,860 | 140,155 (Direct) | View |
| 2023-08-28 Sale | 2023-08-29 6:47 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,512 | $1.45 | $5,092 | 143,875 (Direct) | View |
| 2023-05-25 Sale | 2023-05-26 7:29 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,635 | $1.4196 | $5,160 | 147,387 (Direct) | View |
| 2023-02-27 Sale | 2023-02-28 6:22 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,599 | $1.6812 | $6,051 | 151,022 (Direct) | View |
| 2022-11-28 Sale | 2022-11-29 5:33 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,532 | $2.7196 | $9,606 | 154,621 (Direct) | View |
| 2022-08-26 Sale | 2022-08-29 9:14 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,655 | $4.0162 | $14,679 | 158,153 (Direct) | View |
| 2022-05-26 Sale | 2022-05-27 5:27 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,596 | $1.9011 | $6,836 | 161,808 (Direct) | View |
| 2022-02-28 Sale | 2022-03-01 9:10 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 3,998 | $2.7795 | $11,112 | 165,404 (Direct) | View |
| 2021-11-26 Sale | 2021-11-29 7:48 pm | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 7,579 | $4.8112 | $36,464 | 169,402 (Direct) | View |
| 2019-07-01 Sale | 2019-07-02 5:41 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. Chief Financial Officer | 2,669 | $1.3115 | $3,500 | 77,870 (Direct) | View |
| 2019-05-15 Sale | 2019-05-16 5:21 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. Chief Financial Officer | 10,000 | $1.4089 | $14,089 | 88,039 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-21 Option Award | 2024-03-25 8:36 pm | N/A 2034-03-20 | LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-13 8:29 pm | N/A 2034-03-12 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-02-25 Exercise | 2024-02-27 7:54 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 136,750 (Direct) | View |
| 2023-11-25 Exercise | 2023-11-28 7:06 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 140,155 (Direct) | View |
| 2023-08-25 Exercise | 2023-08-29 6:47 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,888 | $0 | 143,875 (Direct) | View |
| 2023-05-25 Exercise | 2023-05-26 7:29 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 147,387 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-17 4:57 pm | N/A 2033-03-16 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-02-25 Exercise | 2023-02-28 6:22 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 151,022 (Direct) | View |
| 2022-11-25 Exercise | 2022-11-29 5:33 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 154,621 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-29 9:14 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 158,153 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 5:27 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 161,808 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:35 pm | N/A 2032-03-17 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 195,000 | $0 | 195,000 (Direct) | View |
| 2022-02-25 Exercise | 2022-03-01 9:10 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 6,889 | $0 | 165,404 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-29 7:48 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 13,777 | $0 | 169,402 (Direct) | View |
| 2021-09-28 Exercise | 2021-09-29 6:04 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 10,000 | $0.9 | 155,577 (Direct) | View |
| 2021-09-28 Exercise | 2021-09-29 6:04 pm | N/A 2029-07-30 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 10,000 | $0 | 155,577 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 5:49 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 12,000 | $0.9 | 155,577 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 5:49 pm | N/A 2029-07-30 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 12,000 | $0 | 155,577 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:00 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO | 78,912 | $0 | 78,912 (Direct) | View |
Ownership | 2021-02-24 8:10 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | VIRX | Chevallard Daniel R. Chief Executive Officer | 0 | $0 | 320,908 (Direct) | View |
| 2019-05-14 Option Award(A) | 2019-05-16 5:57 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. Chief Financial Officer | 8,000 | $0 | 8,000 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:21 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. Chief Financial Officer | 63,414 | $0 | 88,039 (Direct) | View |